EUVIMEDEUVIMED entdecken
Open Access

A miniaturized wash-free microfluidic assay for electrical impedance-based assessment of red blood cell-mediated microvascular occlusion

Solomon Oshabaheebwa, Christopher A Delianides, Akshay A Patwardhan, Erica N Evans, Zoe Sekyonda, Allison Bode, Faith M Apio, Cissy K Mutuluuza, Vivien A Sheehan, Michael A Suster, Umut A Gurkan, Pedram Mohseni

Biosensors and Bioelectronics · 2024

DOI: 10.1016/j.bios.2024.116352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2024. Verfasst von Solomon Oshabaheebwa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Erythrocytes, Biosensing Techniques, Electric Impedance. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, FIC NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The production of HbS - an abnormal hemoglobin (Hb) - in sickle cell disease (SCD) results in poorly deformable red blood cells (RBCs) that are prone to microcapillary occlusion, causing tissue ischemia and organ damage. Novel treatments, including gene therapy, may reduce SCD morbidity, but methods to functionally evaluate RBCs remain limited. Previously, we presented the microfluidic impedance red cell assay (MIRCA) for rapid assessment of RBC deformability, employing electrical impedance-based readout to measure RBC occlusion of progressively narrowing micropillar openings. We describe herein the design, development, validation, and clinical utility of the next-generation MIRCA assay, featuring enhanced portability, rapidity, and usability. It incorporates a miniaturized impedance analyzer and features a simplified wash-free operation that yields an occlusion index (OI) within 15 min as a new metric for RBC occlusion. We show a correlation between OI and percent fetal hemoglobin (%HbF), other laboratory biomarkers of RBC hemolysis, and SCD severity. To demonstrate the assay's versatility, we tested RBC samples from treatment-naïve SCD patients in Uganda that yielded OI levels similar to those from hydroxyurea (HU)-treated patients in the U.S., highlighting the role of %HbF in protecting against microcapillary occlusion independent of other pharmacological effects. The MIRCA assay could also identify a subset of HU-treated patients with high occlusion risks, suggesting that they may require treatment adjustments including a second-line therapy to improve their outcomes. This work demonstrates the potential of the MIRCA assay for accelerated evaluation of RBC health, function, and therapeutic effect in an ex vivo model of the microcapillary networks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellErythrocytesBiosensing TechniquesElectric ImpedanceHumansEquipment DesignErythrocyte DeformabilityMicrofluidic Analytical TechniquesHemolysisLab-On-A-Chip Devices

Stichwörter der Autor:innen

BiosensingElectrical impedanceHemorheologyMicrofluidicsSickle cell diseaseVaso-occlusion

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Department of Electrical, Computer, and Systems Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Department of Pediatrics, Emory University School of Medicine & Children's Healthcare of Atlanta, Atlanta, GA, 30322, USA.
  • Department of Hematology and Oncology, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
  • Joint Clinical Research Centre, Kampala, Uganda.
  • Department of Pediatrics, Emory University School of Medicine & Children's Healthcare of Atlanta, Atlanta, GA, 30322, USA. Electronic address: vivien.sheehan@emory.edu.

Förderung

  • NHLBI NIH HHS
  • FIC NIH HHS
  • NIBIB NIH HHS
  • NIAID NIH HHS
  • National Heart Lung and Blood Institute
  • National Institutes of Health Office of the Director
  • National Institutes of Health
  • Case Western Reserve University

Zitieren

APA

Oshabaheebwa, S., Delianides, C. A., Patwardhan, A. A., Evans, E. N., Sekyonda, Z., Bode, A., Apio, F. M., Mutuluuza, C. K., Sheehan, V. A., Suster, M. A., Gurkan, U. A., & Mohseni, P. (2024). A miniaturized wash-free microfluidic assay for electrical impedance-based assessment of red blood cell-mediated microvascular occlusion. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2024.116352

Vancouver

Oshabaheebwa S, Delianides CA, Patwardhan AA, Evans EN, Sekyonda Z, Bode A, et al. A miniaturized wash-free microfluidic assay for electrical impedance-based assessment of red blood cell-mediated microvascular occlusion. Biosensors and Bioelectronics. 2024. doi:10.1016/j.bios.2024.116352

BibTeX
@article{Oshabaheebwa2024,
  author = {Oshabaheebwa, Solomon and Delianides, Christopher A and Patwardhan, Akshay A and Evans, Erica N and Sekyonda, Zoe and Bode, Allison and Apio, Faith M and Mutuluuza, Cissy K and Sheehan, Vivien A and Suster, Michael A and Gurkan, Umut A and Mohseni, Pedram},
  title = {A miniaturized wash-free microfluidic assay for electrical impedance-based assessment of red blood cell-mediated microvascular occlusion},
  journal = {Biosensors and Bioelectronics},
  year = {2024},
  doi = {10.1016/j.bios.2024.116352}
}
Kostenlos starten →